{"id":"NCT01391286","sponsor":"Allergan","briefTitle":"Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis","officialTitle":"A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-daily Application of Bimatoprost Solution 0.03% Compared to Vehicle to Treat Chemotherapy-induced Hypotrichosis of the Eyelashes in Japanese Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07-01","primaryCompletion":"2012-05-25","completion":"2012-05-25","firstPosted":"2011-07-12","resultsPosted":"2013-07-09","lastUpdate":"2019-07-08"},"enrollment":36,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Eyelash Hypotrichosis"],"interventions":[{"type":"DRUG","name":"bimatoprost solution 0.03%","otherNames":["LATISSEÂ®"]},{"type":"DRUG","name":"bimatoprost vehicle solution","otherNames":[]}],"arms":[{"label":"bimatoprost solution 0.03%","type":"EXPERIMENTAL"},{"label":"bimatoprost vehicle solution","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes following chemotherapy treatment.","primaryOutcome":{"measure":"Percentage of Participants With at Least a 1-Grade Increase in Overall Eyelash Prominence Using the Global Eyelash Assessment Scale (GEA)","timeFrame":"Baseline, Month 4","effectByArm":[{"arm":"Bimatoprost Solution 0.03%","deltaMin":88.9,"sd":null},{"arm":"Bimatoprost Vehicle Solution","deltaMin":27.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["24643895"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":18},"commonTop":["Radiation skin injury","Nasopharyngitis","Skin hyperpigmentation","Eye pruritus","Arthralgia"]}}